Risedronate sodium Prescribing at WIGHT PRIMARY PARTNERSHIPS LTD
Drugs affecting bone metabolism | Endocrine System
Items (12m)
510
Total Quantity
2,312
NHS Cost
£621
vs National Avg
+320.4%
WIGHT PRIMARY PARTNERSHIPS LTD prescribed 510 items of Risedronate sodium over the last 12 months at a cost of £621 to the NHS. This is 320.4% above the national average prescribing rate. Risedronate sodium is classified under Drugs affecting bone metabolism in the BNF.
Monthly Prescribing Trend
Jul 2026
42
Jul 2026
41
Jul 2026
48
Jul 2026
34
Jul 2026
44
Jul 2026
42
Jul 2026
46
Jul 2026
48
Jul 2026
39
Jul 2026
43
Jul 2026
46
Jul 2026
37
Prescribing Details
| Total Items | 510 |
|---|---|
| Total Quantity | 2,312 |
| Total NHS Cost | £621 |
| Presentations | 2 different forms |
| vs National Average | +320.4% |
Risedronate sodium Prescribing Comparison
| This practice | 510 items |
|---|---|
| National average per practice | 121 items |
| Difference | +320.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.